期刊文献+

环孢素A聚氰基丙烯酸酯纳米粒工艺优化及性质研究

Studies on Preparation of Cyclosporine A-loaded Polycyanoacrylate Nanoparticles
暂未订购
导出
摘要 目的:筛选和优化环孢素A-聚氰基丙烯酸酯纳米粒处方工艺,并初步考察了纳米粒的相关理化性质。方法:反相高效液相色谱测定环孢素含量;聚氰基丙烯酸酯为载体材料,均匀设计法对乳化聚合技术制备载药纳米粒中油/水比例,乳化刑、蒸发温度和乳化时间进行优化:透射电镜对纳米粒特性和形态进行了鉴定分析。结果:以水:溶剂为5:1作溶剂,0.1%泊洛沙姆为增溶剂,温度为50℃下所制备的环孢素纳米粒分布均匀集中,呈单峰,粒子呈圆形,平均粒径为(39.75±0.50)nm,回收率为(92.21±2.06)%,包封率为(99.57±0.04)%,载药量为(15.33±0.01)%。结论:优化处方工艺制备的环孢素A-景氰基丙烯酸酯纳米微粒有良好稳定性和分散性。 Objective: To select the best preparation technique of intestines dissolved materials, polycyanoacrylate nanoparticles loaded cyclosporine A. Methods: The cyclosporine A nanoparticles were prepared by the emulsified- polymerization method. The contents of cyclosporine A were determined by RP-HPLC. The preparation technique and prescription of nanoparticls were optimized by uniformity design regulation, Results: The nanoparticles had a small particle size and the high recovery and envelopment rate when the ratio of water and solvent phase was 5:1, using 0.1% pluronic F68 as solubilizing agent. The average particle size was 39,75 ± 0,50 nm, the yield was 92.21 ± 2,06%, the drug entrapped efficiency was 99.57 ±0.04% and the drug loading was 1.53 ± 0.01%. Conclusion: The optimal prescription and preparation technique of cyclosporine-loaded polycyanoacrylate nanoparticles were obtained.
机构地区 苏州大学药学院
出处 《抗感染药学》 2007年第4期154-157,186,共5页 Anti-infection Pharmacy
基金 江苏省卫生厅基金资助(编号:H2006030) 苏州大学医学发展基金资助(编号:Ee132503)
关键词 环孢素A 纳米粒 制备 均匀设计 Cyclosporine A nanoparticles preparation uniformity design
  • 相关文献

参考文献6

二级参考文献21

  • 1[1]Noble S, Markham A. Cyclosporin: a review of pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation(Neoral) [J]. Drugs, 1995,50(5):924-941.
  • 2[2]Lavelle EC, Sharif S, Thomas NW, et al. The importance of gastrointestinal uptake of particles in the design of oral delivery systems [J]. Adv Drug Deliv Rev, 1995,18(1):5-17.
  • 3[3]Desai MP, Labhasetwar V, Amidon GL, et al. Gastrointestinal of biodegradable microparticles [J]. Pharm Res, 1996,13(12):1838-1845.
  • 4[4]The Pharmacopoeia Commission of P.R. of China. Pharmacopoeia of the Peoples′ Republic of China (中华人民共和国药典) [S]. Part II. Beijing: Chemical Industry Press, 2000. Appendix 202.
  • 5[5]Li HS, Ye GQ, Zhao JL, et al. Improved high performance liquid chromatographic determination of cyclosporine A in whole blood samples of rat and rabbit [J]. West China J Pharm Sci(华西药学杂志), 1999,14(2):89-92.
  • 6Jura H, Bader A, Frosch M. In vitro activities of benzimidazoles against echinococcus metacestodes [ J ]. Antimicrob Adents Cheother, 1998,42 ( 5 ) : 1052.
  • 7Lenaerts V, Nagelkerke JF. In vivo uptake of polyisobutylcyanocrylate nanopartides by rats liver kupffer, endothelial, and parenchymal cell[J]. J Pharm Sci, 1984,73(7) :980.
  • 8Keyser JL,Poupaert JH,Dumont P. Poly(diethyl methylide nmatonate)nanoparticles as a potential drug carrier: preparation,distributions and elimination after intravenous and peroral administration[ J ]. J Pharm Sci, 1991,80(1 ):67.
  • 9Speiser P. Nanoparticles and liposomes: a state of the art [J ].Mettods Find Eacp Clin Pharmacol , 1991,13(5) :337.
  • 10黎洪珊,赵京玲,魏树礼.环孢菌素A聚乳酸纳米粒胶体的制备和大鼠的口服吸收[J].中国药学杂志,1999,34(8):532-536. 被引量:27

共引文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部